AngioDynamics (ANGO) says preliminary Q3 earnings are expected to be between $0.04 - $0.06 per...
AngioDynamics (ANGO) says preliminary Q3 earnings are expected to be between $0.04 - $0.06 per share, below analyst consensus of $0.09 per share. Revenues are anticipated to be $81M, also lower than estimates of $87M and below prior year revenues of $83M as well. The company blames the miss on sales attrition in its vascular access business, softness in procedure volumes in the peripheral vascular business, and delays in capital-equipment purchases that reduced oncology/surgery sales. Shares -4.6% AH.
From other sites
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs